IperionX LimitedIPXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank75
3Y CAGR-55.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-55.6%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 43.81% |
| 2024 | 6.47% |
| 2023 | 671.59% |
| 2022 | 498.88% |
| 2021 | 0.00% |
| 2020 | 0.00% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2017 | 0.00% |